Legislative Activity
Track Donald's sponsored bills, co-sponsored legislation, and voting record
This bill mandates that Medicare Part D drug coinsurance be based on the actual, lower cost of the drug, not the inflated wholesale price, starting in 2026.
Donald Davis
Representative
NC
Donald Davis
Representative
NC
The "Reducing Drug Prices for Seniors Act" mandates that Medicare Part D drug coinsurance be calculated based on a drug's actual acquisition cost rather than the wholesale price, beginning January 1, 2026. This change affects costs incurred between the annual deductible and the out-of-pocket threshold. The actual acquisition cost is defined as the negotiated price less any manufacturer concessions.
The Modern Authentication of Pharmaceuticals Act of 2025 mandates physical chemical identifiers on controlled substance doses and updates product verification methods.
Donald Davis
Representative
NC
Donald Davis
Representative
NC
The Modern Authentication of Pharmaceuticals Act of 2025 aims to enhance the security of the pharmaceutical supply chain by requiring a physical chemical identifier on each dose of solid oral controlled substances manufactured five years after the law's enactment. It revises the definition of "product identifier" to include either a standardized graphic with specific information or a physical chemical identifier. The act also updates the definition of "verification" to include confirming product authenticity using the physical chemical identifier.